Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUALIFY: Aripiprazole Once-monthly vs Paliperidone Palmitate in Schizophrenia
NCT01795547Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Feb 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in schizophrenia, sponsored by Lundbeck. Started Feb 2013; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01795547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01795547.